AWS Life Sciences Symposium 2026 Event Brief The 2026 Annual AWS Life Sciences Symposium brought together more than two thousand leaders across biopharma, technology, and research to […]
AI at a Scale will Reshape Life Sciences Read More »
Axendia’s Analysis of the Root Causes and Our Recommendations to Prevent Them There has been a lot of buzz around FDA’s warning letter which for
FDA Calls Out Inappropriate Use of Artificial Intelligence Read More »
QAD Adaptive and Champion AI Briefing Note QAD Leadership including Tom Roberts, Vice President of Strategic Industry Development and Robyn Coward, Life Sciences Director, outlined
Moving from Systems of Record to Systems of Action Read More »
Medidata NEXT NY 2026 Event Brief The life sciences industry is navigating a period of continuous disruption driven by scientific complexity, operational pressure, regulatory modernization,
AI Agents and Virtual Twins Redefine the Future of Life Sciences Read More »
Rockwell Automation Fair 2025 Event Brief Axendia participated in The Rockwell Automation Fair 2025, held in Chicago, IL. This year, the event attracted over 15,000
Intelligent Autonomous Systems Fuel the Future of Industry Read More »
Insights from the 2025 Blue Mountain Summit The 2025 Blue Mountain Summit brought together industry leaders, experts, and innovators to discuss the latest trends, practices,
Blue Mountain Unveils Ambitious Product Roadmap Read More »
2025 Veeva R&D And Quality Summit Event Brief Axendia is grateful for the opportunity to once again cover the Veeva R&D and Quality Summit in Boston from
Industry Platform for Life Sciences Adds AI and Standard Applications Read More »
In 2005, Axendia was founded to meet a critical need: trusted, strategic, and actionable advice from experts who truly understand the intricate balance of business,
Axendia at 20: Forging the Future of Life Sciences! Read More »
What you need to know about the Bipartisan MAPS Act In the age of continuous disruption, from pandemics to geopolitical conflicts and trade uncertainty, the
Congress Wants to Map the Pharmaceutical Supply Chain Read More »
EQTY Lab Briefing Note Axendia was briefed by the executive team at EQTY Lab, including Dr. Tina Dr. Morrison, VP Scientific Strategy and Alistair Dootson, Head of Life
Driving AI Integrity in Life Sciences Read More »
FDA Expects That Records be Submitted in Electronic Format Nestled within FDA’s final guidance on Remote Regulatory Assessments (RRAs) is a pivotal and decisive statement:
Why Paper Won’t Cut It In FDA’s Remote Oversight Era Read More »
Insights from the 2025 Honeywell Life Sciences World Tour Axendia participated in the Honeywell Life Sciences World Tour USA. Under the theme “Innovation for a
Accelerating Innovation for a Healthier Future Read More »
